Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/24/2023* 08:30 EST Earnings Call Q4 2022 -- -- --
02/24/2023* -- Results Q4 2022 -- 0.88 --
11/03/2022 08:30 EST Earnings Call Q3 2022 -- -- --
11/03/2022 -- Results Q3 2022 0.64 0.76 -16.27%
08/03/2022 08:30 EST Earnings Call Q2 2022 -- -- --
08/03/2022 -- Results Q2 2022 0.51 0.85 -40.15%
05/04/2022 08:30 EST Earnings Call Q1 2022 -- -- --
05/04/2022 -- Results Q1 2022 0.64 0.83 -23.09%
*Estimated Date/Time

Earnings

Next Report Date 02/24/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/03/2022
Beat/Miss Upgrade
Return Since -4.72%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.
URL https://www.pacira.com
Investor Relations URL https://investor.pacira.com/
HQ State/Province Florida
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Blend
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-13.39%
-57.94%
41.33%
-5.76%
5.30%
32.10%
0.55%
-21.47%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-13.26%
122.5%
-84.97%
214.2%
-25.12%
6.35%
26.35%
15.04%
-26.28%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-84.33%
-9.04%
-23.93%
70.05%
-17.52%
10.42%
-13.60%
-24.30%
-68.65%
-18.25%
-29.46%
-55.16%
-57.46%
-66.95%
321.7%
-47.71%
-87.61%
As of December 02, 2022.

Profile

Edit
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.
URL https://www.pacira.com
Investor Relations URL https://investor.pacira.com/
HQ State/Province Florida
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Blend
Next Earnings Release Feb. 24, 2023 (est.)
Last Earnings Release Nov. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
SPYGX 34.81M USD 4.71%
IATNX 32.47M USD 4.19%
DFRIX 61.23M USD 3.45%
XPH 6.248M USD 2.87%
PJP 9.363M USD 2.85%
PXSAX 14.36M USD 2.51%
PSCH 7.130M USD 2.12%
WRGCX 32.95M USD 2.06%
PILL 208520.0 USD 1.78%
LCGRX 24.06M USD 1.21%
FTXH 494849.0 USD 1.13%
IHE 3.507M USD 0.82%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter PCRX Tweets